The "buy or build" conundrum remains central to many technology decisions made by insurers.
A new report from New York-based
Indeed, given the ongoing profusion of configurable vendor offerings and the improving interoperability or best-of-breed solutions, making the case for in-house development has become harder.
“It is becoming increasingly difficult to justify building as more and more packaged solutions become available to buy while existing ones grow better every year,” the report states.
Nonetheless, a case can still be made, especially for ancillary, non-core systems. In-house development may in some cases impart a competitive advantage and save carriers on licensing fees. Moreover, a custom build can be tailored to fit existing infrastructure and staff.
Accordingly, the authors expect this discussion to be ongoing. “Although valid reasons to build are limited, the debate over buying versus building continues.”